MARKET

NAMS

NAMS

NewAmsterdam Pharma Company N.V
NASDAQ
33.61
-0.08
-0.22%
Opening 12:35 12/18 EST
OPEN
34.15
PREV CLOSE
33.68
HIGH
34.58
LOW
32.85
VOLUME
379.09K
TURNOVER
--
52 WEEK HIGH
42.00
52 WEEK LOW
14.06
MARKET CAP
3.81B
P/E (TTM)
-16.6444
1D
5D
1M
3M
1Y
5Y
1D
NewAmsterdam Pharma Is Maintained at Buy by Stifel
Dow Jones · 2d ago
NewAmsterdam Pharma Price Target Raised to $50.00/Share From $44.00 by Stifel
Dow Jones · 2d ago
Stifel Maintains Buy on NewAmsterdam Pharma Co, Raises Price Target to $50
Benzinga · 2d ago
Stifel Nicolaus Keeps Their Buy Rating on NewAmsterdam Pharma Company (NAMS)
TipRanks · 2d ago
Weekly Report: what happened at NAMS last week (1208-1212)?
Weekly Report · 3d ago
National Presto, Garrett Motion, and More Stocks See Action From Activist Investors
Barron‘s · 5d ago
Weekly Report: what happened at NAMS last week (1201-1205)?
Weekly Report · 12/08 10:20
Tracking Stanley Druckenmiller's Duquesne Family Office Portfolio - Q3 2025 Update
Seeking Alpha · 12/07 23:56
More
About NAMS
NewAmsterdam Pharma Company NV is a Netherlands based company. NewAmsterdam Pharma operates as a clinical-stage company and focuses on the research and development of transformative oral therapies for major cardiometabolic diseases. The Company is investigating obicetrapib, an oral, low-dose and once-daily, cholesteryl ester transfer protein (CETP) inhibitor, as the low-density lipoprotein cholesterol (LDL-C) lowering therapy to be used as an adjunct statin therapy for high-risk cardiovascular disease (CVD) patients. The Company is also testing obicetrapib as a fixed-dose combination therapy with ezetimibe in a secondary Phase 2 trial, ROSE2, for other diseases such as Alzheimer’s disease. The Company strives to offer its products around the world.

Webull offers NewAmsterdam Pharma Company NV stock information, including NASDAQ: NAMS real-time market quotes, financial reports, professional analyst ratings, in-depth charts, corporate actions, NAMS stock news, and many more online research tools to help you make informed decisions. Trade stocks for 0 commission and 0 contract fees on the web version for easy and convenient access, or download the Webull app and trade on the go.

You can practice and explore trading NAMS stock methods without spending real money on the virtual paper trading platform.